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Background: To investigate the association between metabolic syndrome, including its factors, and gallstone
disease (GSD) in a Taiwanese population.
Methods: We conducted a cross-sectional study during 2011 ~ 2012. A total of 12050 subjects who completed a
questionnaire and underwent physical examination, laboratory tests and abdominal ultrasonography formed the
study population.
Results: The prevalences of metabolic syndrome and gallstone disease were 24.09% and 6.16%. In an age- and
sex-adjusted logistic regression model, metabolic syndrome was associated with gallstone disease (OR = 1.61; P < 0.0001).
Age, abdominal obesity, and lower high-density lipoprotein cholesterol were associated with gallstone disease after
adjusting for other factors. Females had a higher odds ratio than males in waist circumference for GSD, whereas males
had a lower odds ratio than females in HDL-C for GSD.
Conclusions: The present study suggests that metabolic syndrome is related to gallstone disease. Waist circumference
and high-density lipoprotein cholesterol are all associated with GSD. Men and women may possibly have different
priorities and strategies to reduce the burden of GSD.
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Metabolic syndrome (MetS) means the presence of
multiple risk factors for cardiovascular disease (CVD).
The report from the National Cholesterol Education
Program’s Adult Treatment Panel III (ATP III) identified
6 components of metabolic syndrome that are related
to CVD: abdominal obesity, atherogenic dyslipidemia,
raised blood pressure, insulin resistance, glucose intoler-
ance, a pro-inflammatory state and a prothrombotic
state [1]. MetS increases the risks of atherosclerosis and
CVD. Some studies have also suggested that it may be
related to some gastrointestinal tract diseases, such as
fatty liver, nonalcoholic steatohepatitis, and unexplained
liver cirrhosis [2].
Gallstone disease (GSD) is a chronic disease that con-
sumes a lot of economic and medical resources [3]. It* Correspondence: a102067@cmu.edu.tw
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unless otherwise stated.not only affects patients’ life quality, but also is associ-
ated with the potential risks of the development of
cholecystitis, pancreatitis, biliary tract obstruction and
gall bladder cancer [2,4]. In Taiwan, the overall preva-
lence of gallstone disease is around 4.3 - 10.7% [4,5].
If the risk factors of GSD can be identified, more inter-
ventions can be introduced earlier to prevent the disease.
According to studies in Western countries, sex, age,
body mass index (BMI), hyperlipidemia, usage of oral
contraceptives, alcohol consumption, diabetes mellitus
(DM), and race have been reported to be closely
related to GSD [6,7]. Among these, hyperlipidemia,
obesity and diabetes mellitus (DM) are all diagnostic
factors of MetS.
Generally speaking, the compositions of gallstones are
different between Western countries and Asia. In Western
countries, cholesterol gallstones predominate, whereas pig-
ment and mixed stone are more common in Asia [8]. Many
studies in Western countries indicate that MetS is a risk
factor for GSD [2,9]. However, in Taiwan, few studies have. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to 2005 also failed to show a significant association between
MetS and GSD [8].
With the increasing incidence of MetS and a change
in the Taiwanese dietary pattern, the relationships be-
tween metabolic factors and GSD must be explored.
Therefore, the aims of this study were to establish
whether there is an association between MetS and
GSD in Taiwanese and analyze the relationships be-
tween metabolic factors and GSD.
Methods
Subjects and data collection
We conducted a cross-sectional study in the health exam-
ination center of Changhua Christian Hospital, Changhua
City, Taiwan. Subjects who underwent a health examination
during 2011 to 2012 formed our study population. The
study protocol was approved by the Ethics Committee
of Changhua Christian Hospital, Taiwan (CCH IRB
No: 121113).
A total of 14,318 subjects who underwent physical
examination, laboratory tests and abdominal sonography
were enrolled. However, there were 2,073 subjects who
had undergone a health exam in two successive years.
The exclusion criteria also included a history of cholecyst-
ectomy (n = 163) and age <20 (n = 32). Finally, 12,050
subjects were included in our study.
Subjects were asked to complete a questionnaire that
requested information on demographic data, age, gender,
alcohol consumption, family history and past history (in-
cluding diabetes mellitus, hypertension, chronic liver
disease, etc.). Physical examination was also performed
for our subjects and included body height, body weight,
waist circumference, and blood pressure. Waist circum-
ference (to the nearest 0.1 cm) was measured at the
midpoint between the lower border of the rib and iliac
crest. The blood pressure readings were obtained after
subjects had sat down and rested for 10 min.
We collected blood data from participants after they
had fasted overnight ( > 8 hours). Data enrolled for ana-
lysis included age, fasting plasma glucose (FPG), trigly-
ceride (TG), total cholesterol, high-density lipoprotein
cholesterol (HDL-C), and low-density lipoprotein chol-
esterol (LDL-C).
Diagnostic criteria
MetS was defined as the presence of three or more of the
following five criteria proposed by the Taiwan National
Health Department [10,11]: (1) abdominal obesity, de-
fined as a waist circumference in men ≥ 90 cm and in
women ≥ 80 cm; (2) hypertriglyceridemia: (higher TG) ≥
150 mg/dL; (3) lower HDL-C: serum HDL-C < 40 mg/
dL in men and < 50 mg/dL in women; (4) elevated blood
pressure (systolic blood pressure ≥ 130 mmHg or diastolicblood pressure ≥ 85 mmHg or hypertension history (includ-
ing self-reported or medical record); and (5) hyperglycemia:
fasting plasma glucose (FPG) ≥ 100 mg/dL or DM history
(including self-reported or medical record).
The diagnosis of GSD was determined based on the
sonographic findings by an experienced gastrointestinal
physician, who was unaware of the objectives of the
study and blinded to the laboratory values. Gallstones
were defined by the presence of strong intraluminal
echoes that were gravity dependent or that attenuated
ultrasound transmission (acoustic shadowing) in the
gallbladder. We did not perform further analysis of gall-
stone composition.
Our sample population was formed from asymptom-
atic subjects who visited our health examination center.
If the subjects had symptoms such as right upper ab-
dominal pain and nausea, they were referred to the out-
patient department and not be included in our study.
Statistical analyses
To identify the risk factors for GSD, metabolic factors
were further separated into categorical variables based
on the definition of MetS in our study. All statistical
analyses were conducted using SAS version 9.2. Student’s
t test was applied to compare the differences between GSD
and non-GSD groups for all continuous variables. The X2
test was used to compare the differences between GSD and
non-GSD groups for all categorical variables. An age- and
sex-adjusted logistic regression model was used to test
the association between MetS and GSD. We also con-
structed univariate and multivariate logistic regression
models to examine the associations between metabolic
factors and GSD.
Results
Among the 12,050 subjects, the prevalence of MetS was
27.20% (28.56% in men and 18.80% in women). The preva-
lence of GSD was 6.16% (6.15% in men and 6.17% in
women). There were significant differences in the means of
age, BMI, waist circumference, systolic blood pressure, dia-
stolic blood pressure, HDL-C, TG and fasting blood glucose
between the GSD and non-GSD groups (Table 1).
Table 2 shows the crude (non-controlled) risks from the
univariate analysis. Abdominal obesity, elevated blood pres-
sure, hyperglycemia, lower HDL-C, and higher TG were all
associated with a higher probability of GSD. However,
there were no statistical differences between genders.
Among the above-mentioned factors, abdominal obes-
ity was most significantly and independently associated
with GSD (OR = 1.88; Table 2).
The odds ratio of MetS for GSD was 1.75 (95% CI =
1.42-2.15) in men and 2.46 (95% CI = 1.92-3.14) in
women, and the overall odds ratio of MetS for GSD was
1.99 (95% CI = 1.70-2.33) (Table 3). When MetS was
Table 1 Mean differences in continuous variables between cases and controls (mean ± SD)
Variable GSD (n = 734) Non-GSD (n =11180) P
Mean SD Mean SD
Age 52.7398 11.7932 46.9330 11.9712 < 0.0001
BMI 25.2892 3.6809 24.0816 3.6198 < 0.0001
Total cholesterol (TC) 191.8 37.2738 192.8 35.6617 0.4866
LDL-C 119.9 33.1849 119.9 31.0059 0.9784
Waist circumference 84.4238 10.0897 81.1618 9.9753 < 0.0001
Systolic BP 127.8 17.7644 122.6 17.1131 < 0.0001
Diastolic BP 81.0479 11.0727 78.8193 10.5878 < 0.0001
HDL-C 46.1391 12.1260 49.1702 12.7905 < 0.0001
Triglyceride (TG) 126.8 111.9 115.1 105.0 0.0039
FPG 100.3 24.2483 96.5119 21.3288 < 0.0001
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GSD was still significant after adjusting for age and gen-
der (OR = 1.61; 95% CI = 1.366-1.898; P < 0.0001).
Further considering what factors account most for
GSD, multivariate logistic regression analysis showedTable 2 Comparison of metabolic factors between the GSD an
Variable
GSD n = 741 Non-GSD
n % n
Sex
Male 410 3.44 6253
Female 324 2.72 4927
Abdominal obesity
Larger 318 2.69 3260
Normal 406 3.44 7834
Systolic BP
Higher (≥130 mmHg) 321 2.70 3463
Lower (<130 mmHg) 410 3.45 7702
Diastolic BP
Higher (≥85 mmHg) 248 2.08 3062
Lower (<85 mmHg) 483 4.06 8103
Elevated blood pressure
Higher 412 3.46 4708
Normal 321 2.70 6457
HDL-C
Lower 316 2.94 3510
Normal 374 3.48 6546
TG
Higher 184 1.57 2367
Normal 538 4.58 8655
Hyperglycemia
Higher 250 2.15 2754
Normal 465 3.99 8183that age (OR = 1.037; 95% CI = 1.029-1.046), waist
circumference, (OR = 1.013; 95% CI = 1.004-1.023) and
HDL-C (OR = 0.985; 95% CI = 0.977-0.993) were asso-
ciated with GSD after adjusting for the other factors
(Table 4).d non-GSD group
n = 11182
























1.5975 (1.3617, 1.8740) <0.0001
70.23
Table 3 Association of metabolic syndrome (MetS) with
gallstone disease by sex
MS status
GSD Non-GSD
OR (95% CI) P
n (%) n (%)
Male
Non-MetS 237 (5.14) 4378 (94.86)
1.75 (1.42-2.15) < 0.0001
MetS 158 (8.64) 1670 (91.36)
Female
Non-MetS 203 (4.91) 3931 (95.09)
2.46 (1.92-3.14) < 0.0001
MetS 107 (11.26) 843 (88.74)
Total
Non-MetS 440 (5.03) 8309 (94.97)
1.99 (1.70-2.33) < 0.0001
MetS 265 (9.54) 2513 (90.46)
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metabolic factors between genders, the multivariate
logistic regression analysis showed that age, waist cir-
cumference, HDL-C were significantly and independ-
ently associated with GSD in both genders. Females
had a higher odds ratio than males in waist circumfer-
ence for GSD, whereas males had a lower odds ratio
than females in HDL-C for GSD (Table 4).
Discussion
The prevalence of GSD in our study was 6.16%. It ac-
cords with past studies, which reported the prevalence
to be 3-11% in Taiwan [4,5,8]. The prevalence of GSD in
Taiwan is a little lower than that in western countries
(10-15%). The prevalence of MetS in our study subjects
was about 27.20%, which is also in accordance with the
current statistics from Taiwan [10,12].
Our study is the first Taiwanese study to show that the
presence of MetS is associated with an increased risk of
GSD (OR = 1.61; 95% CI = 1.366-1.898; P < 0.001) after
adjusting for age and sex. Of all the factors of MetS,
waist circumference and HDL-C were associated with
GSD after adjusting for the other factors.
The metabolic syndrome seems to have 3 potential
etiological categories: obesity and disorders of adiposeTable 4 Age and metabolic risk factors for GSD by multiple lo
Males
OR 95% CI P OR
Age 1.040 (1.030-1.051) < 0.0001 1.031
Waist circumference 1.014 (1.001-1.027) 0.0378 1.027
Systolic BP 1.004 (0.994-1.014) 0.4790 0.995
Diastolic BP 1.007 (0.992-1.022) 0.3450 1.013
HDL-C 0.969 (0.957-0.982) <0.0001 0.988
TG 1.000 (0.998-1.001) 0.4438 0.999
FPG 0.999 (0.994-1.003) 0.5308 1.002
Continuous variables: Age, Waist circumference, Systolic BP, Diastolic BP, HDL-C, TGtissue; insulin resistance; and a constellation of inde-
pendent factors that mediate specific components of the
metabolic syndrome. Other factors - aging, proinflam-
matory state, and hormonal changes - have been impli-
cated as contributors as well [1]. The formation of GSD
is related to bile acid metabolism, gallbladder motility,
inflammation, and decreased bowel movement [7]. Factors
that are related to GSD may affect any one of the above
mechanisms. Factors of MetS, with the exception of hyper-
tension, have also been reported as independent risk factors
for GSD in many studies [4,5,7].
Our study suggests that gallstone formation increases
with age, but not with gender. The more elderly had
long-term exposure to many chronic factors, such as
hyperlipidemia, alcohol consumption, and diabetes mel-
litus (DM). They may exhibit decreased motility of the
gallbladder, thus causing GSD [4,5,13].
As in the other Asian studies [4,5,8], our study also in-
dicates that gender is not related to GSD. Most previous
western studies have shown that females are more likely
to develop GSD than males [14,15]. It is generally be-
lieved that sex hormones are related to cholesterol me-
tabolism, indicating that gender may be related to
cholesterol stones [13]. However, pigment stones are
often related to hemolysis, infection, and liver disease.
The relationship between gender and GSD is probably
different between Asia and Western population.
When adjusting for age and other metabolic factors,
the present study revealed that waist circumference was
associated with GSD. We also suggest that it is the most
important metabolic factor for females with GSD. Obes-
ity is a chronic inflammatory condition and is strongly
linked to raised levels of pro-inflammatory factors [16].
It will increase liver secretion of cholesterol and make
the bile supersaturated by increasing biliary secretion of
cholesterol and causing GSD formation [8,13,17].
In our study, people with a higher blood pressure were
more likely to have GSD than those with a normal blood
pressure. However, after adjusting for age, sex and other
metabolic factors, this likelihood was not significant.
The mechanism by which abnormal blood pressuregistic regression
Females All
95% CI P OR 95% CI P
(1.018-1.044) < 0.0001 1.037 (1.029-1.046) < 0.0001
(1.012-1.043) 0.0006 1.013 (1.004-1.023) 0.0066
(0.985-1.006) 0.4005 0.999 (0.992-1.007) 0.8253
(0.996, 1.030) 0.1486 1.008 (0.997, 1.020) 0.1506
(0.978, 0.999) 0.0330 0.985 (0.977-0.993) 0.0001
(0.997-1.001) 0.4585 0.999 (0.998-1.1001) 0.2685
(0.997, 1.008) 0.4361 1.000 (0.997-1.004) 0.8728
, FPG.
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cholelithiasis in Asian obese patients is significantly as-
sociated with increased diastolic blood pressure. It is
possible that people with hypertension may have more
sympathetic nerve activities that easily inhibit bowel
movement and cause GSD [18].
In line with previous research reporting lower HDL-C
to be a risk factor for GSD [7,9], our study also arrived
at this conclusion. Biliary cholesterol is mainly derived
from HDL-C, with previous observations indicating that
insulin resistance is associated with a low serum HDL-C
concentration [19]. This may cause a high catabolic rate
of HDL-C particles, which increases the rate of biliary
cholesterol secretion [7,13,19].
In the present study, TG was related to GSD in the
univariate analysis but not in the multiple logistic regres-
sion. One study indicated that in patients with higher
TG, supersaturated bile may be related to the presence
of obesity rather than to higher TG itself. However, the
study also revealed that a higher TG level leads to de-
creased gallbladder contraction, which can easily lead to
GSD [20]. The relationship between TG and GSD is
complicated.
Whether DM is a risk factor for GSD remains contro-
versial. While several western studies have suggested
that DM is a risk factor for GSD, we here have showed
that although hyperglycemia was more common in the
GSD group in univariate analysis, this was not the case
in the multiple logistic regression. Although study has
shown that rats with hyperinsulinemia have the specific
FOXO1 protein, which can increase the formation of chol-
esterol into bile [21]. Furthermore, hyperglycemia inhibits
bile secretion from the liver and disturbs gallbladder con-
traction, and may affect gallbladder motility [13].
The current study indicates that lower HDL-C may be
the most important metabolic factor for GSD in men,
whereas in women, abdominal obesity had a higher odds
ratio for GSD. It was previously found that women with
abdominal obesity are prone to develop GSD [8]. The
reason why HDL-C is the most important metabolic fac-
tor for GSD in men still requires further investigation.
Almost 10% of individuals with asymptomatic chole-
lithiasis in the general population can be expected to de-
velop symptoms or complications that require treatment
within five years. One study demonstrated that meta-
bolic syndrome, diabetes and gallstone size were associ-
ated with complicated gallstone diseases [22,23]. For the
above findings, we should pay attention to the relation
between MetS and GSD.
There are several limitations to this study. First, the
study design was retrospective and cross-sectional. Fur-
ther longitudinal study is needed to clarify the true rela-
tionship between MetS and GSD. Second, subjects who
underwent a health check-up were enrolled in the study.This may result in selection bias, such as the Hawthorne
Effect. Furthermore, certain recognized GSD risk factors,
such as a family history of GSD and weight loss history,
were not included in the present study. Further research is
needed to determine the true relationship between MetS
and GSD considering the above factors. Research into
Taiwanese gallstone composition can also be performed.
Conclusions
This study found that MetS is related to GSD in the
population of Taiwan. Waist circumference and HDL-C
are associated with GSD. Men and women may possibly
have different priorities and strategies to reduce the
burden of GSD.
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